EUVIMEDEUVIMED entdecken
Crossref

Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK – VEGF / MMPs signaling pathway

Li Tian, YuQi Huang iD, Yan Liu, JiangWei Liu, Yan Liu

IUBMB Life · 2024

DOI: 10.1002/iub.2861 ↗

Kurz gefasst

Fachartikel in der Zeitschrift IUBMB Life, 2024. Verfasst von Li Tian und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary Surgery, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China. Hauptthemen laut MEDLINE: Carcinoma, Hepatocellular, Liver Neoplasms, Isoxazoles, Cell Proliferation. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 68 Literaturangaben. Gefördert von: Joint Fund of Guizhou Provincial Department of Science and Technology.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Parecoxib, a well‐recognized nonsteroidal anti‐inflammatory drug, has been reported to possess anticancer properties in various tumor types. In this work, we aimed to investigate the potential anticancer effects of parecoxib on hepatocellular carcinoma (HCC) cells. To assess the impact of parecoxib on HCC cell proliferation, we employed Cell Counting Kit‐8, colony formation, and 5‐ethynyl‐2′‐deoxyuridine assays. Hoechst/propidium iodide (PI) double staining and flow cytometry were performed to evaluate apoptosis and cell cycle analysis. Wound healing and transwell assays were utilized to assess cell migration and invasion. Tube formation assay was employed to analyze angiogenesis. Protein levels were determined using western blotting, and mRNA expression levels were assessed using quantitative real‐time polymerase chain reaction (PCR). A xenograft mouse model was used to confirm the antitumor effects of parecoxib on HCC tumors in vivo. Our data demonstrated that parecoxib effectively inhibited the proliferation of HCC cells in a dose‐ and time‐dependent manner. In addition, parecoxib induced cell cycle arrest in the G2 phase and promoted apoptosis. Moreover, parecoxib hindered tumor migration and invasion by impeding the epithelial–mesenchymal transition process. Further investigation showed that parecoxib could significantly suppress angiogenesis through the inhibition of extracellular signal‐regulated kinase (ERK)–vascular endothelial growth factor (VEGF) axis. Notably, treatment with the ERK activator phorbol myristate acetate upregulated the expression of matrix metalloproteinase (MMP)‐2, MMP‐9, and VEGF and reversed the function of parecoxib in HCC cells. Besides, parecoxib displayed its antitumor efficacy in vivo. Collectively, our results suggest that parecoxib ameliorates HCC progression by regulating proliferation, cell cycle, apoptosis, migration, invasion, and angiogenesis through the ERK–VEGF/MMPs signaling pathway.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, HepatocellularLiver NeoplasmsIsoxazolesCell ProliferationNeovascularization, PathologicVascular Endothelial Growth Factor AApoptosisCell MovementHumansAnimalsMiceXenograft Model Antitumor AssaysMice, NudeSignal TransductionMice, Inbred BALB CGene Expression Regulation, NeoplasticCarcinogenesisMAP Kinase Signaling SystemMatrix Metalloproteinase 9MaleCell Line, TumorAngiogenesis

Stichwörter der Autor:innen

COX‐2 inhibitorangiogenesishepatocellular carcinomaoncogenesisparecoxib

Substanzen

parecoxibIsoxazolesVascular Endothelial Growth Factor AVEGFA protein, humanMatrix Metalloproteinase 9

Autor:innen und Institutionen

  • Department of Hepatobiliary Surgery, Guizhou Provincial People's Hospital, Guiyang, Guizhou, China.
  • Department of Infectious Diseases, The First Affiliated Hospital, Zhejiang University School of Medicine, Zhejiang, Hangzhou, China.

ORCID-Profile: YuQi Huang

Förderung

  • Joint Fund of Guizhou Provincial Department of Science and Technology

Zitieren

APA

Tian, L., Huang, Y., Liu, Y., Liu, J., & Liu, Y. (2024). Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK – VEGF / MMPs signaling pathway. IUBMB Life. https://doi.org/10.1002/iub.2861

Vancouver

Tian L, Huang Y, Liu Y, Liu J, Liu Y. Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK – VEGF / MMPs signaling pathway. IUBMB Life. 2024. doi:10.1002/iub.2861

BibTeX
@article{Tian2024,
  author = {Tian, Li and Huang, YuQi and Liu, Yan and Liu, JiangWei and Liu, Yan},
  title = {Parecoxib inhibits tumorigenesis and angiogenesis in hepatocellular carcinoma through ERK – VEGF / MMPs signaling pathway},
  journal = {IUBMB Life},
  year = {2024},
  doi = {10.1002/iub.2861}
}
Kostenlos starten →